Summary

Eligibility
for people ages 45-49 (full criteria)
Location
at La Jolla, California
Dates
study started
completion around
Principal Investigator
by Joshua Demb, PhD
Headshot of Joshua Demb
Joshua Demb

Description

Summary

The objective of this pilot study is to compare the effectiveness of mailed outreach of two stool based tests, Cologuard and the fecal immunochemical test (FIT) in screening eligible adults ages 45-49 receiving care at the University of California San Diego Health system.

Official Title

Comparative Effectiveness of Mailed Cologuard Outreach to Mailed FIT Outreach

Details

Adults ages 45-49 who are insured, deemed average risk and not currently up to date with colorectal cancer screening will be enrolled. Eligible participants will be randomized to either mailed Cologuard outreach, facilitated by Exact Sciences or mailed FIT outreach. Colorectal cancer screening completion within 3 months will be measured as the primary outcome, in addition to secondary recruitment and intervention-based feasibility outcomes to demonstrate the potential for a larger randomized controlled trial.

Keywords

Colorectal Cancer, screening, early detection, stool blood test, Colorectal Neoplasms, Cologuard, Fecal Immunochemical Test, Mailed Cologuard Outreach

Eligibility

You can join if…

Open to people ages 45-49

  • Adults ages 45-49 with EHR documentation indicating that the patient has an assigned primary care provider at UCSD Health
  • ≥1 UCSD Health System health visit within the last year
  • Resides in San Diego or Imperial County
  • Currently not up to date with CRC screening
  • Insured by private, public or other health insurance.

You CAN'T join if...

Location

  • University of California San Diego accepting new patients
    La Jolla California 92126 United States

Lead Scientist at UCSD

  • Joshua Demb, PhD
    Postdoctoral Scholar, Medicine, Vc-health Sciences-schools. Authored (or co-authored) 41 research publications

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Diego
ID
NCT06173375
Study Type
Interventional
Participants
Expecting 100 study participants
Last Updated